Boothbay Fund Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,770
| Closed | -$645K | – | 1429 |
|
|
2024
Q3 | $645K | Buy |
+9,770
| New | +$645K | 0.01% | 751 |
|
|
2024
Q2 | – | Sell |
-11,974
| Closed | -$1.14M | – | 1443 |
|
|
2024
Q1 | $1.14M | Buy |
+11,974
| New | +$1.14M | 0.02% | 605 |
|
|
2023
Q4 | – | Sell |
-6,028
| Closed | -$418K | – | 1565 |
|
|
2023
Q3 | $418K | Buy |
+6,028
| New | +$418K | 0.01% | 939 |
|
|
2023
Q2 | – | Sell |
-5,279
| Closed | -$437K | – | 1704 |
|
|
2023
Q1 | $437K | Buy |
5,279
+920
| +21% | +$76.1K | 0.01% | 1101 |
|
|
2022
Q4 | $325K | Sell |
4,359
-1,512
| -26% | -$113K | 0.01% | 1135 |
|
|
2022
Q3 | $485K | Buy |
5,871
+3,693
| +170% | +$305K | 0.01% | 1085 |
|
|
2022
Q2 | $207K | Sell |
2,178
-1,145
| -34% | -$109K | 0.01% | 1480 |
|
|
2022
Q1 | $391K | Buy |
+3,323
| New | +$391K | 0.01% | 1133 |
|
|
2021
Q2 | – | Sell |
-6,178
| Closed | -$517K | – | 1743 |
|
|
2021
Q1 | $517K | Buy |
+6,178
| New | +$517K | 0.02% | 752 |
|
|
2020
Q1 | – | Sell |
-3,756
| Closed | -$292K | – | 815 |
|
|
2019
Q4 | $292K | Buy |
+3,756
| New | +$292K | 0.03% | 513 |
|
|
2019
Q3 | – | Sell |
-3,717
| Closed | -$229K | – | 716 |
|
|
2019
Q2 | $229K | Buy |
+3,717
| New | +$229K | 0.02% | 487 |
|
|
2018
Q1 | – | Sell |
-5,418
| Closed | -$204K | – | 631 |
|
|
2017
Q4 | $204K | Buy |
+5,418
| New | +$204K | 0.03% | 508 |
|
|
2017
Q1 | – | Sell |
-16,659
| Closed | -$520 | – | 713 |
|
|
2016
Q4 | $520 | Buy |
+16,659
| New | +$520 | 0.12% | 178 |
|